Ophthotech Corp (OPHT)

3.40
0.02 0.59
NASDAQ : Health Care
Prev Close 3.38
Open 3.38
Day Low/High 3.37 / 3.47
52 Wk Low/High 35.72 / 80.00
Volume 233.39K
Avg Volume 1.51M
Exchange NASDAQ
Shares Outstanding 35.81M
Market Cap 117.45M
EPS -5.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ophthotech Corporation Selected Financial Data (unaudited) (in Thousands, Except Per Share Data)

Ophthotech Corporation Selected Financial Data (unaudited) (in Thousands, Except Per Share Data)

Ophthotech Corporation (Nasdaq:OPHT) today announced financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided a general business update.

OPHT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Ophthotech Corporation And A Lead Plaintiff Deadline Of March 13, 2017

OPHT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Ophthotech Corporation And A Lead Plaintiff Deadline Of March 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Ophthotech Corporation (NASDAQ: OPHT) securities...

Ophthotech Corporation To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call On Tuesday, February 28, 2017

Ophthotech Corporation To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call On Tuesday, February 28, 2017

Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its fourth quarter and full year 2016 financial and operating results on Tuesday, February 28, 2017.

INVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors Of Ophthotech Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 13, 2017

INVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors Of Ophthotech Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 13, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Ophthotech Corporation ("Ophthotech") (NASDAQ: OPHT) between May...

OPHT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Ophthotech Corporation And A Lead Plaintiff Deadline Of March 13, 2017

OPHT SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Ophthotech Corporation And A Lead Plaintiff Deadline Of March 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Ophthotech Corporation (NASDAQ:OPHT) securities...

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Ophthotech Corporation To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Ophthotech Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Ophthotech Announces Strategic Review Plan

Ophthotech Announces Strategic Review Plan

Ophthotech Corporation (Nasdaq:OPHT) today announced that it has initiated a plan to review its strategic alternatives in order to maximize shareholder value.

Robbins Arroyo LLP: Ophthotech Corporation (OPHT) Misled Shareholders According To A Recently Filed Class Action

Robbins Arroyo LLP: Ophthotech Corporation (OPHT) Misled Shareholders According To A Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Ophthotech Corporation (NASDAQGS: OPHT) in the U.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Learn to Shift Gears in Your Trading

Learn to Shift Gears in Your Trading

When you seek to find the right structure or combination, you can get hurt.

Dow Posts Another Record Close but Nasdaq Slips Amid Tech Declines

Dow Posts Another Record Close but Nasdaq Slips Amid Tech Declines

The Dow posts a record close with the S&P 500 lower, while tech stocks dragged on the Nasdaq as Wall Street looks to a Fed decision on interest rates Tuesday.

Dow Sets Record as Oil Settles Higher but Nasdaq Slips Amid Tech Declines

Dow Sets Record as Oil Settles Higher but Nasdaq Slips Amid Tech Declines

The Dow rises but pares gains as Wall Street looks to a Fed decision on interest rates later in the week.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of An Investigation Involving Possible Securities Fraud Violations By Ophthotech Corporation And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of An Investigation Involving Possible Securities Fraud Violations By Ophthotech Corporation And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Ophthotech Corporation ("Ophthotech" or the "Company") (NASDAQ:OPHT) concerning possible violations of federal securities laws by the Company...

How to Trade Monday's Most Active Stocks - AMD, CBS, Ophthotech and More

How to Trade Monday's Most Active Stocks - AMD, CBS, Ophthotech and More

Here's a technical look on how to trade some of the most active stocks on the market this week.

Oversold Conditions For Ophthotech (OPHT)

Oversold Conditions For Ophthotech (OPHT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Dow Hits Record, Gets Lift From Energy Sector as Oil Prices Surge

Dow Hits Record, Gets Lift From Energy Sector as Oil Prices Surge

Stocks are mixed Monday as oil prices surge after non-OPEC countries agree to cut production and markets anticipate Fed moves.

Ophthotech Plunges on Eye-Drug-Study Failure

Ophthotech Plunges on Eye-Drug-Study Failure

Fovista combined with the currently approved drug Lucentis failed to improve the vision of patients with wet, age-related macular degeneration compared to Lucentis alone.

Jim Cramer -- Ophthotech's Loss a Cautionary Win for Regeneron

Jim Cramer -- Ophthotech's Loss a Cautionary Win for Regeneron

Shares of Ophthotech are plunging after the company's Phase 3 results failed to meet specific endpoints.

Ophthtech Shares Plunge as Drug Fails in Late Stage Trial

Ophthtech Shares Plunge as Drug Fails in Late Stage Trial

A drug made by Ophthotech failed in a late stage trial, sending shares of the stock plunging.

Ophthotech Announces Results From Pivotal Phase 3 Trials Of Fovista® In Wet Age-Related Macular Degeneration

Ophthotech Announces Results From Pivotal Phase 3 Trials Of Fovista® In Wet Age-Related Macular Degeneration

Ophthotech Corporation (Nasdaq:OPHT) today announced that the pre-specified primary endpoint of mean change in visual acuity at 12 months was not achieved in its two pivotal Phase 3 clinical trials investigating...